CytomX Therapeutics (CTMX) Total Non-Current Liabilities (2014 - 2026)
CytomX Therapeutics (CTMX) reported Total Non-Current Liabilities of $74.69 million for Q2 2026, up 46.7% from $50.91 million a year earlier and up 113.4% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics posted Total Non-Current Liabilities of $48.21 million, down 58.8% from FY2024.
- Total Non-Current Liabilities has declined for three consecutive years, with a three-year compound annual growth rate of -48.2% (FY2022 to FY2025).
- By year, Total Non-Current Liabilities came in at $116.87 million in FY2024 (-52.4%), $245.35 million in FY2023 (-29.2%) and $346.64 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Total Non-Current Liabilities since Q4 2024.
- Year over year, Total Non-Current Liabilities gained in 1 of the last eight quarters, with an average decline of 45.7%.
- The high point for year-over-year Total Non-Current Liabilities in five years was Q2 2026 (growth of 46.7%); the low point was Q2 2025 (a decline of 72.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $35 million (Q1 2026), $48.21 million (Q4 2025) and $46.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.26 Bn | 1,105.84 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 618.12 Bn | 536.65 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.25 Bn | 476.36 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.45 Bn | 262.44 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.39 Bn | 235.08 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.30 Bn | 192.70 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.55 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.92 Bn | 116.56 Bn | 10.94 Bn | 97.04 Bn |
| 10 | CytomX Therapeutics | 530.93 Mn | -426.74 Mn | - | 74.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 74.69 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Dec 31, 2025 | 48.21 Mn |
| Sep 30, 2025 | 46.57 Mn |
| Jun 30, 2025 | 50.91 Mn |
| Mar 31, 2025 | 69.27 Mn |
| Dec 31, 2024 | 116.87 Mn |
| Sep 30, 2024 | 158.38 Mn |
| Jun 30, 2024 | 186.45 Mn |
| Mar 31, 2024 | 212.43 Mn |
| Dec 31, 2023 | 245.35 Mn |
| Sep 30, 2023 | 269.65 Mn |
| Jun 30, 2023 | 294.00 Mn |
| Dec 31, 2022 | 346.64 Mn |
| Jun 30, 2022 | 314.62 Mn |
| Dec 31, 2019 | 314.96 Mn |
| Sep 30, 2019 | 289.47 Mn |
| Jun 30, 2019 | 302.82 Mn |
| Mar 31, 2019 | 320.98 Mn |
| Dec 31, 2018 | 318.23 Mn |
API Access
CytomX Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();